Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find 'chemo brain' no figment of the imagination

09.10.2006
UCLA imaging study shows changes in patients' brain function even 10 years after chemotherapy

Cancer survivors, take note. The mental fog and forgetfulness of "chemo brain" are no figment of your imagination.

A new UCLA study shows that chemotherapy causes changes to the brain's metabolism and blood flow that can linger at least 10 years after treatment. Reported Oct. 5 in the online edition of the journal Breast Cancer Research and Treatment, the findings may help to explain the disrupted thought processes and confusion that plague many chemotherapy patients.

"People with 'chemo brain' often can't focus, remember things or multitask the way they did before chemotherapy," explained Dr. Daniel Silverman, head of neuronuclear imaging and associate professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA. "Our study demonstrates for the first time that patients suffering from these cognitive symptoms have specific alterations in brain metabolism."

Silverman and his colleagues used positron emission tomography (PET) to scan the brains of 21 women who had undergone surgery to remove breast tumors five to 10 years earlier. Sixteen of them had been treated with chemotherapy regimens near the time of their surgeries to reduce the risk of cancer recurrence.

The team compared PET images evaluating the chemotherapy patients' brain function to PET scans from five breast-cancer patients who underwent surgery only, and 13 control subjects who did not have breast cancer or chemotherapy.

As the women performed a series of short-term memory exercises, the UCLA team measured blood flow to their brains. The researchers also ran a scan of the patients' resting brain metabolism after the women finished the exercises.

"The PET scans show a link between chemo-brain symptoms and lower metabolism in a key region of the frontal cortex," explained Silverman, a member of UCLA's Jonsson Comprehensive Cancer Center. "We found that the lower the patient's resting brain metabolism rate was, the more difficulty she had performing the memory test."

The scans revealed that blood flow to the frontal cortex and cerebellum spiked as the chemotherapy patients performed the memory tests, indicating a rapid jump in these brain regions' activity level.

"The same area of the frontal lobe that showed lower resting metabolism displayed a substantial leap in activity when the patients were performing the memory exercise," said Silverman. "In effect, these women's brains were working harder than the control subjects' to recall the same information."

Finally, the researchers discovered that women who underwent hormonal therapy in addition to chemotherapy displayed changes to their basal ganglia, a part of the brain that works to bridge thought and action. On average, these women showed an 8 percent drop in resting metabolism in this brain region.

"Chemotherapy used to be prescribed primarily to treat metastatic disease," observed Silverman. "Now it's common for doctors to administer chemotherapy to patients near the time of surgery to prevent metastasis. As many of these patients become long-term survivors, doctors are recognizing lasting side-effects of chemotherapy, and, in particular, the kind of chemo-brain symptoms we are studying."

"Our findings suggest that PET scans could be used to monitor the effects of chemotherapy on brain metabolism," he added. "The approach could be easily added to current whole-body PET or PET/CT scans already being used to monitor patients for tumor response to therapy."

Although chemo brain is an acknowledged phenomenon, doctors don't know what mechanisms cause it. More studies are needed to uncover how the damage occurs and whether modification of chemotherapy drugs could prevent it.

The National Cancer Institute recently awarded a five-year grant to oncologist Dr. Patricia Ganz, who is organizing a long-term study on chemo brain of a larger group of breast-cancer survivors with Silverman and their colleagues at UCLA.

More than 211,000 new cases of breast cancer are diagnosed a year, making it the most common cancer in women. Experts estimate that at least 25 percent of chemotherapy patients are affected by chemo brain, and a recent study by the University of Minnesota reported an 82 percent rate.

Elaine Schmidt | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New pop-up strategy inspired by cuts, not folds

27.02.2017 | Materials Sciences

Sandia uses confined nanoparticles to improve hydrogen storage materials performance

27.02.2017 | Interdisciplinary Research

Decoding the genome's cryptic language

27.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>